Biotech Webinar - When to Pursue International Markets in Biotech - A European's Perspective

AITC, BioAlabama, and ADOC

Register Online

Presented by Kristinn Gretarsson

Mr. Kristinn Gretarsson has joined the AITC as a Director of International Business Development. Mr. Gretarsson has 25 years’ experience in international business as a frontline manager, CEO and board member of companies in medical, biotech and the financial sector. He has extensive experience in driving growth, entering new markets, product development and brand building. Mr. Gretarsson has led two companies through ISO 9001 certification and secured CE marking and FDA approval for medical devices, diagnostic aids and skin care products. Mr. Gretarsson was the CEO of ORF Genetics and BIOEFFECT, a world leading company in the development and production of recombinant proteins.